Amanda Kirane Selected Research

apricoxib

9/2012	Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.
9/2012	Epithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amanda Kirane Research Topics

Disease

6	Neoplasms (Cancer) 01/2020 - 01/2011
3	Neoplasm Metastasis (Metastasis) 01/2019 - 09/2012
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 09/2012
2	Adenocarcinoma 01/2019 - 01/2011
1	Hypoxia (Hypoxemia) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2018
1	Sarcoma (Soft Tissue Sarcoma) 03/2016
1	Thrombosis (Thrombus) 09/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2012
1	Colorectal Neoplasms (Colorectal Cancer) 09/2012
1	Carcinoma (Carcinomatosis) 09/2012

Drug/Important Bio-Agent (IBA)

2	apricoxibIBA 09/2012 - 09/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	CollagenIBA 01/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2018
1	Interleukin-2 (IL2)IBA 01/2018
1	RetinoidsIBA 01/2018
1	Vitamin K FDA Link 09/2015
1	Axl Receptor Tyrosine KinaseIBA 09/2015
1	Warfarin (Coumadin)FDA LinkGeneric 09/2015
1	Gemcitabine FDA Link 09/2012
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2012
1	Antineoplastic Agents (Antineoplastics)IBA 09/2012
1	Proteins (Proteins, Gene)FDA Link 01/2011

Therapy/Procedure

4	Therapeutics 01/2019 - 01/2011
2	Drug Therapy (Chemotherapy) 09/2015 - 01/2011
1	Immunotherapy 01/2020